The latest prostate cancer news
Study reveals mechanisms behind common mutation and prostate cancer
A new study from the University of Michigan Rogel Cancer Center, USA, published in Science,…
Browsing: Prostate Cancer
The glucocorticoid receptor is a double-edged sword in prostate cancer
A recent study from the Institute of Biomedicine at the University of Eastern Finland shows…
ASCO 2025: Adding niraparib to standard treatment may slow cancer growth for some patients with mCSPC
Results from the international phase 3 AMPLTUDE clinical trial found that adding niraparib to abiraterone…
ASCO 2025: ARCHES and Australian-led ENZAMET prostate cancer trials to present XTANDI® (enzalutamide) data
New data, to be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting…
Novel blood-based biomarker analysis provides insights to improve therapy decisions and treatment outcomes for patients with metastatic disease
New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer…
Advanced imaging and targeted therapy help men with prostate cancer safely defer surgery and radiation therapy
In a new study led by the UCLA Health Jonsson Comprehensive Cancer Centre, USA, investigators show…
More men with prostate cancer are avoiding unnecessary surgery
Prostate cancer is a leading cause of cancer-related death among men in the United States.…
“Chimaeric RNA” opens door to treatments tailored for specific patient populations
Prostate cancer has distinct genetic properties in different groups of men that can be targeted to…
Simple spit test could finally turn the tide on prostate cancer
A spit test, where a sample can be collected at home, is more accurate at…
EAU 2025: Waterjet surgery for an enlarged prostate can offer relief, without compromising sexual enjoyment
Using a high-pressure water jet to operate on an enlarged prostate can better preserve the…